Outcomes of Transcatheter Pulmonary Valve Replacement and Surgical Pulmonary Valve Replacement: A Cohort Analysis
- PMID: 39131481
- PMCID: PMC11307640
- DOI: 10.1016/j.jscai.2022.100408
Outcomes of Transcatheter Pulmonary Valve Replacement and Surgical Pulmonary Valve Replacement: A Cohort Analysis
Abstract
Background: Transcatheter pulmonary valve replacement (TPVR) has become an alternative to surgical pulmonary valve placement (SPVR) for patients after tetralogy of Fallot repair. This study compared the outcomes of TPVR with those of SPVR.
Methods: We reviewed data from patients who underwent pulmonary valve replacement with a median of 2 years of follow-up.
Results: Between 2010 and 2021, 215 patients underwent pulmonary valve replacement (72 TPVR and 143 SPVR). The median size of the right ventricular end-diastolic volume index in the TPVR group was 165 mL/m2 (IQR, 136-190) and 184 mL/m2 (IQR, 163-230) in the SPVR group (P = .001). The median value of the maximum landing zone at the right ventricular outflow tract (RVOT) in patients with native RVOT was 26 mm (IQR, 24-28) in the 43 patients in the TPVR group and 31 mm (IQR, 28-34) in the 101 patients in the SPVR group (P < .001). The median size of the pulmonary valve implant for the native RVOT in the TPVR group was 29.0 mm (IQR, 26.0-29.0) and 24.0 mm (IQR, 24.0-24.0) in the SPVR group (P < .001). There were no deaths in the TPVR group and 8 deaths in the SPVR group (P = .041). Major complications and the length of hospitalization were lower in the TPVR group (P = .001). After 2 years, the mean decrease in QRS duration was 5 milliseconds (IQR, 1-14) in the TPVR group and 1 millisecond (IQR, -4 to 10) in the SPVR group (P = .006).
Conclusions: TPVR allows for larger implants, resulting in lower mortality, shorter hospital stays, and fewer major cardiac events. SPVR may be preferable in patients with larger (>30 mm) native RVOT and in those who require concomitant surgical procedures.
Keywords: surgical pulmonary valve replacement; tetralogy of Fallot; transcatheter pulmonary valve replacement.
© 2022 The Author(s).
Figures



Similar articles
-
Single-Barrel, Double-Barrel, and Fenestrated Endografts to Facilitate Transcatheter Pulmonary Valve Replacement in Large RVOT.JACC Cardiovasc Interv. 2020 Dec 14;13(23):2755-2765. doi: 10.1016/j.jcin.2020.08.024. JACC Cardiovasc Interv. 2020. PMID: 33303113 Free PMC article.
-
Early outcomes in patients undergoing transcatheter versus surgical pulmonary valve replacement.Heart. 2017 Sep;103(18):1455-1460. doi: 10.1136/heartjnl-2016-310776. Epub 2017 Mar 28. Heart. 2017. PMID: 28351873
-
Repeat Pulmonary Valve Replacement: Similar Intermediate-Term Outcomes With Surgical and Transcatheter Procedures.JACC Cardiovasc Interv. 2018 Dec 24;11(24):2495-2503. doi: 10.1016/j.jcin.2018.07.042. Epub 2018 Nov 28. JACC Cardiovasc Interv. 2018. PMID: 30503596
-
Transcatheter Versus Surgical Pulmonary Valve Replacement: A Systemic Review and Meta-Analysis.Ann Thorac Surg. 2020 Nov;110(5):1751-1761. doi: 10.1016/j.athoracsur.2020.03.007. Epub 2020 Apr 5. Ann Thorac Surg. 2020. PMID: 32268142
-
Transcatheter pulmonary valve replacement in pediatric patients.Expert Rev Med Devices. 2020 Jun;17(6):541-554. doi: 10.1080/17434440.2020.1775578. Expert Rev Med Devices. 2020. PMID: 32459512 Review.
Cited by
-
Adaptation of Aortic Bioprosthetic Valves for Pulmonary Position: Comparative Analysis of Transcatheter and Surgical Valves.J Cardiovasc Transl Res. 2024 Dec;17(6):1338-1346. doi: 10.1007/s12265-024-10528-4. Epub 2024 Oct 18. J Cardiovasc Transl Res. 2024. PMID: 39422840
-
Prevalence of Aspirin Resistance in Patients with Transcatheter Pulmonary Valve Replacement.Catheter Cardiovasc Interv. 2025 Apr;105(5):1230-1235. doi: 10.1002/ccd.31440. Epub 2025 Feb 11. Catheter Cardiovasc Interv. 2025. PMID: 39930947 Free PMC article.
-
Comparative effects of transcatheter versus surgical pulmonary valve replacement: A systematic review and meta-analysis.PLoS One. 2025 May 20;20(5):e0322041. doi: 10.1371/journal.pone.0322041. eCollection 2025. PLoS One. 2025. PMID: 40392782 Free PMC article.
References
-
- Marelli A.J., Mackie A.S., Ionescu-Ittu R., Rahme E., Pilote L. Congenital heart disease in the general population: changing prevalence and age distribution. Circulation. 2007;115(2):163–172. - PubMed
-
- Horneffer P.J., Zahka K.G., Rowe S.A., et al. Long-term results of total repair of tetralogy of Fallot in childhood. Ann Thorac Surg. 1990;50(2):179–183. discussion 83-85. - PubMed
-
- Katz N.M., Blackstone E.H., Kirklin J.W., Pacifico A.D., Bargeron Jr., L.M. Late survival and symptoms after repair of tetralogy of Fallot. Circulation. 1982;65(2):403–410. - PubMed
-
- Gatzoulis M.A., Balaji S., Webber S.A., et al. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet. 2000;356(9234):975–981. - PubMed
-
- Gatzoulis M.A., Till J.A., Somerville J., Redington A.N. Mechanoelectrical interaction in tetralogy of Fallot. QRS prolongation relates to right ventricular size and predicts malignant ventricular arrhythmias and sudden death. Circulation. 1995;92(2):231–237. - PubMed
LinkOut - more resources
Full Text Sources